Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scDiabody-CH3)  (SCDBC-049)

Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD20/anti-CD22 diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.

Datasheet